| Description |
1 online resource (x, 341 pages) : illustrations, portraits 25 cm |
| Contents |
Contents -- Preface -- Acknowledgment -- Contributors -- 1. Fever and neutropenia: An historical perspective -- 2. Overview of pharmacokinetic and pharmacodynamic principles of anti-infective dosing in the neutropenic patient -- 3. Controversies and quandaries: The design of clinical trials in fever and neutropenia -- 4. Current epidemiology of infections in neutropenic cancer patients -- 5. Infections in patients with solid tumors -- 6. Infections in patients with hematologic malignancies |
|
7. Evaluation and management of fever in the neutropenic hematopoietic stem cell transplant patient8. Initial clinical evaluation and risk assessment of the febrile neutropenic cancer patient -- 9. Risk-adjusted management of the febrile neutropenic cancer patient -- 10. Evaluation and management of vascular access device infections in febrile neutropenic cancer patients -- 11. Special considerations in children with fever and neutropenia -- 12. Prophylaxis of infections -- 13. Cytokines and WBC transfusions |
|
14. Clinical practical guidelines in patients with fever and neutropenia15. Healthcare economic concepts in fever and neutropenia -- 16. Fever in the neutropenic patient: Past lessons and future prospects -- Index |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Febrile neutropenia -- Treatment
|
|
Neutropenia -- chemically induced
|
|
Neutropenia -- therapy
|
|
Antineoplastic Agents -- adverse effects
|
|
Fever -- chemically induced
|
|
MEDICAL -- Hematology.
|
|
Antineoplastic agents -- Side effects
|
|
Febrile neutropenia
|
| Form |
Electronic book
|
| Author |
Rolston, Kenneth V. I
|
|
Rubenstein, Edward B., 1957-
|
| ISBN |
0203215273 |
|
9780203215272 |
|
